NCT01121315已完成不适用
A Retrospective Epidemiological Study to Investigate Outcome and Mortality With Glucose Lowering Drug Treatment in Primary Care
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 58,326
- 试验地点
- 1
- 主要终点
- Composite end-point consisting of Cardiovascular Disease, elective coronary revascularisation and mortality
研究概览
简要总结
To describe the type II diabetes population in primary care with special reference to treatment, other diseases and mortality during the last decade. To test the hypothesis that the type or combination of per oral glucose lowering drugs have different effects on the risk of cardiovascular disease and diabetic complications.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with type II diabetes, according to medical records, diagnosis, prescription or lab assessments
排除标准
- •Patients followed by physician for less than 6 months after diagnosis of Diabetes type II
结局指标
主要结局
Composite end-point consisting of Cardiovascular Disease, elective coronary revascularisation and mortality
时间窗: The endpoints will be extracted from the medical records on one occassion, covering a period of one decade.
次要结局
- Retinopathy, renal failure, hypoglycaemic episodes, other diabetic complications(The endpoints will be extracted from the medical records on one occasion, covering a period of one decade.)
- Time from: Metformin (MET) to Insulin (INS) versus Metformin (MET) -> Metformin (MET)+Sulfonylurea (SU) ->Insulin (INS)(The endpoints will be extracted from the medical records on one occasion, covering a period of one decade.)
- Number of consultations in primary care. Number of hospitalisations(The endpoints will be extracted from the medical records on one occasion, covering a period of one decade.)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and AfricaDiabetes Mellitus, Type 2NCT05317845Novo Nordisk A/S4,089
已完成
不适用
Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)Type 2 DiabetesNCT03694470AstraZeneca10,000
已完成
不适用
Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)Gestational DiabetesNCT03644004Hospices Civils de Lyon173
Unknown
不适用
Prevalence of Macrovascular Disease in Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00298844Odense University Hospital350
已完成
不适用
Incidence of Type 2 Diabetes in the di@Bet.es StudyDiabetes Mellitus, Type 2NCT02542735Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2,408